18 March 2025
EMA: Publication of EU medicine agencies’ network strategy to 2028
The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) have published their joint EU medicines agencies’ network strategy to 2028 (EMANS). The strategy is titled “Seizing opportunities in a changing medicines landscape” and is a comprehensive update of the five-year strategy plan which was developed to cover the period 2021 to 2025. It will guide the European medicines regulatory network over the next few years, including the preparation for and response to public health emergencies and threats such as antimicrobial resistance.
For more information, see here.
More News
-
-
Swissmedic: New strategic Approach to minimizing Animal Testing in the Development of Medicinal Products
-
Swissmedic: The new Pharmacopoea Helvetica 13
-
European Medicines Agency: New oral GLP-1 Medicine for Weight Management and Type 2 Diabetes
-
FOPH: Capital Income of Health Insurers for Premium Reduction – current voluntary System deemed sufficient
-
Swissmedic: Haemovigilance Annual Report 2025
-
Decision C-6534/2024 of 13 October 2026
-
Swissmedic: GMP Compliance by foreign Manufacturers - Simplifications for Industry and Clarification of unresolved Issues
-
European Medicines Agency: Clinical Trial Applications Advice Pilot becomes permanent
-
European Medicines Agency: Highlights of the September 2026 Management Board meeting